ReIGNITE RT boost: an international study testing the accuracy and feasibility of using restriction spectrum imaging (RSI) MRI to guide intraprostatic tumor target …
In a phase III randomized trial, adding a radiation boost to visible tumor (s) on MRI improved
prostate cancer disease-free and metastasis-free survival without additional toxicity …
prostate cancer disease-free and metastasis-free survival without additional toxicity …
Background prostate tissue is quantitatively abnormal on MRI in patients with clinically significant prostate cancer
Background T 2-weighted MRI is well established for detection of clinically significant
prostate cancer (csPCa), but prior studies have primarily focused on T 2 within MRI-visible …
prostate cancer (csPCa), but prior studies have primarily focused on T 2 within MRI-visible …